(Philadelphia,
PA) - Deborah A. Sesok-Pizzini, MD, has joined
the Department of Pathology and Laboratory Medicine
at the University of Pennsylvania School of Medicine,
as an Assistant Professor.
In 1989, Dr. Pizzini graduated from Franklin and Marshall
College, with a BA in Biology. She earned her MD from
Pennsylvania State University College of Medicine and
is presently in the MBA program at Villanova University.
She performed her residency in the Department of Pathology
and Laboratory Medicine; her Patient Oriented Research
Fellowship in the Department of Medicine; and her Blood
Bank and Transfusion Medicine Fellowship, all at the
University of Pennsylvania Health System.
Dr. Pizzini's research focuses on Human Leukocyte Antigens
(HLA) as they relate to the clinical aspects of bone
marrow transplantation, solid organ transplantation,
and platelet alloimmunization. At the Hospital of the
University of Pennsylvania, she is the Assistant Director
of the Blood Bank/Transfusion Medicine Section and Director
of the Stem Cell Laboratory. She helps coordinate the
Blood Bank and Apheresis/Infusion Unit's participation
in extra-departmental sponsored clinical trials.
She is a member of many professional organizations including
the American Association of Blood Banks, College of
American Pathologists and the American Society for Clinical
Pathologists. Her accolades include the Paul E. Strandjord
Young Investigator Award from the Academy of Clinical
Laboratory Physicians and the Transfusion Medicine Fellowship
Award from the American Association of Blood Banks,
among others.
Dr. Pizzini is a diplomate for the American Board of
Pathology in Blood Banking, Transfusion Medicine, and
Clinical Pathology. She has been invited to lecture
on several occasions, most recently at the Internal
Medicine Review Board Course at MCP Hahnemann University
on the topic, "Bleeding Disorders: Thrombophilia:
Prothrombotic Disorders."
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.